Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,863,075
+$13,603,849 QoQ
Shares Held
305,031
+69.9% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#56
of 497 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. ARWR ranks #34 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in ARWR
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,863,075 | 305,031 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $11,259,226 | 179,573 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $8,222,733 | 123,855 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $49,556,611 | 1,436,840 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $34,064,767 | 2,155,998 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $761,342 | 59,760 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,628,700 | 86,633 | Shares | Other | 2025-02-13 | |
| 2023-09-30 | $2,892,501 | 107,648 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $10,735,121 | 301,041 | Shares | Other | 2023-08-14 | |
| 2022-03-31 | $8,406,925 | 182,799 | Shares | Other | 2022-05-16 | |
| 2021-06-30 | $20,736,471 | 250,380 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $22,084,198 | 287,817 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||